130 donorss.
| Date | Contributor | Type | Employer | Occupation | Amount |
|---|---|---|---|---|---|
| 2026-09-30 | Vicki A Rawlinson | IND | Novartis | Head of Executive Coaching | $384.60 |
| 2026-09-30 | Michelle Weese | IND | Novartis | Chief Corporate Affairs Officer | $384.60 |
| 2026-09-30 | Monica Watson | IND | Novartis | VP, Head Legal, Enterp Excellence & Go | $384.60 |
| 2026-09-30 | Melissa McKerracher | IND | US Novartis Pharmaceuticals | CFO US | $384.60 |
| 2026-09-30 | Daniel P Casserly | IND | Novartis | Global Head Public Affairs | $384.60 |
| 2026-09-30 | Alexander D Johnston | IND | US Novartis Pharmaceuticals | VP US Central BPA Head | $384.60 |
| 2026-09-30 | Reshema R Kemps-Polanco | IND | Novartis | EVP, Chief Commercial Officer, US | $384.60 |
| 2026-09-30 | Gail Horwood | IND | Novartis | Chief Mkt & Customer Exp Officer, US | $384.60 |
| 2026-09-30 | Desmond Creary | IND | Novartis | Chief Customer Engagement Officer, US | $384.60 |
| 2026-09-30 | Courtney Piron | IND | Novartis | Head, US Public Affairs | $384.60 |
| 2026-09-30 | Dianne Auclair Rocha | IND | Novartis | SVP, US TA Head Cardiovascular and Met | $300.00 |
| 2026-09-30 | John von Brachel | IND | Novartis | VP, Head of Content Lab | $270.00 |
| 2026-09-30 | Joseph McGowan | IND | Novartis | Head, Federal Government Affairs | $270.00 |
| 2026-09-30 | Shannon McCrudden | IND | Novartis | VP Managed Markets Finance | $270.00 |
| 2026-09-30 | Christopher R McBurney | IND | Novartis | VP & Head, Stakeholder Engagement | $270.00 |
| 2026-09-30 | Sepideh Varon | IND | Novartis | VP & Head of Evidence Generation | $270.00 |
| 2026-09-30 | Rocio P Bueno | IND | Novartis | VP Sr GM Non-Malignant Hem | $270.00 |
| 2026-09-30 | Denise Campbell | IND | Novartis | VP, Head of Marketing Strategy-Oncolog | $270.00 |
| 2026-09-30 | Geoffrey Towle | IND | Novartis | Therapeutic Area Strategy Head, RLT | $270.00 |
| 2026-09-30 | Christopher Chappell | IND | Novartis | VP, GM, Ianalumab Immunology | $270.00 |
| 2026-09-30 | Richard S Reig | IND | Novartis | Head Legal People and Organization | $270.00 |
| 2026-09-30 | Emily Gibb | IND | Novartis | VP, NPS CVM | $270.00 |
| 2026-09-30 | Rodney Gillespie | IND | Novartis | SVP, US TA Head Theranostics | $270.00 |
| 2026-09-30 | Arpan Patel | IND | Novartis | VP, NPS Operations, Vendor Management | $270.00 |
| 2026-09-30 | Lisa Nelson | IND | Novartis | VP, Head of US Public Policy | $270.00 |
| 2026-09-30 | Linda Armstrong | IND | Novartis | Global Head TMDP & GH | $270.00 |
| 2026-09-30 | Mitchell Medland Jr. | IND | Novartis | SVP, US TA Head Oncology | $270.00 |
| 2026-09-30 | Andrew Young | IND | Novartis Pharmaceuticals | Executive Director Launch & BD&L Insig | $230.00 |
| 2026-09-30 | Christy E Siegel | IND | Novartis | SVP, US TA Head Immunology | $230.00 |
| 2026-09-30 | Julie Idelkope | IND | US Novartis Services Inc | Head State Government Affairs | $230.00 |
| 2026-09-30 | Sara Stevens | IND | Novartis | Head, US Issue Advocacy | $230.00 |
| 2026-09-30 | Kathy-Jo B Hayden | IND | Novartis | Director, MA/NPS Counsel NPS Platforms | $230.00 |
| 2026-09-30 | Marion Brooks | IND | Novartis | US Country Head People Experience | $230.00 |
| 2026-09-30 | Mark Tate | IND | Novartis | Executive Director, Oncology Portfolio | $230.00 |
| 2026-09-30 | Nancy Travis | IND | Corporate | Executive Director Trade & Investment | $230.00 |
| 2026-09-30 | Leah Ralph | IND | Novartis | Head, Federal Policy and Analytics | $230.00 |
| 2026-09-30 | Patricia Fitzsimmons | IND | Novartis | Head, Portfolio Policy | $230.00 |
| 2026-09-30 | Philip Martucci | IND | Novartis | ED, People & Culture Communications | $200.00 |
| 2026-09-30 | Jason Young | IND | Novartis | VP, Head of Marketing Strategy | $200.00 |
| 2026-09-30 | Kristin Miller | IND | Novartis | VP, GM MS/Neuroimmunology | $200.00 |
| 2026-09-30 | Nicole Longo | IND | US Novartis Services Inc | Director US Policy & Issues Communicat | $192.30 |
| 2026-09-30 | Courtney Lee-Ashley | IND | Novartis | Director, Federal Gov't Affairs | $192.30 |
| 2026-09-30 | Taylor Booth | IND | Novartis | Director, Fed Gov't Affairs | $192.30 |
| 2026-09-30 | Bailee Barfield | IND | Novartis | Director, Product Reimbursement Policy | $192.30 |
| 2026-09-30 | William Delpino | IND | Novartis | VP, Channel Strategy & Account Mgmt | $192.30 |
| 2026-09-30 | Thomas A Suter | IND | Novartis | Director State Government Affairs | $192.30 |
| 2026-09-30 | Sarah Durr | IND | Novartis | Director, Federal Govt Affairs | $192.30 |
| 2026-09-30 | Peter Stehouwer | IND | Corporate | Director Federal Government Affairs | $192.30 |
| 2026-09-30 | John Russell | IND | Novartis | Director, Market Access Counsel | $192.30 |
| 2026-09-30 | Robert J Rubinsky | IND | Novartis | Chief Market Access & Patient Experien | $192.30 |
| 2026-09-30 | YANCY WILLIAMS | IND | Novartis Services Incorporated | Associate Director, State Government A | $192.30 |
| 2026-09-30 | Monica R Murphy | IND | Novartis | Regional Director | $192.30 |
| 2026-09-30 | Deborah Mercier | IND | Novartis | Dir, Strategy & Comms | $192.30 |
| 2026-09-30 | Liviu Niculescu | IND | Novartis | Chief Medical Officer, US | $192.30 |
| 2026-09-30 | Michele A Angelaccio | IND | Novartis | VP, NPS Strategy, Platforms and Innova | $192.30 |
| 2026-09-30 | Ayushman Hazarika | IND | Novartis | Director, MMF Governance | $192.30 |
| 2026-09-30 | Zachary Allison | IND | US Novartis Pharmaceuticals | VP Head of Sales | $150.00 |
| 2026-09-30 | Patrick Sutton | IND | Novartis | Vice President, Head Launch Machine | $135.00 |
| 2026-09-30 | Kurt Anderson | IND | Novartis | AD State Government Affairs | $120.00 |
| 2026-09-30 | Brianna Earle | IND | Novartis Services Incorporated | Associate Director State Government Af | $115.38 |
| 2026-09-30 | Glenn Astley | IND | Novartis | Dir, HCP Edu Delivery, CVRenal,Neuro, | $115.38 |
| 2026-09-30 | Ashley Calabrese | IND | Novartis | Director, State Legislative Initiative | $115.38 |
| 2026-09-30 | Mary E Corcoran | IND | Novartis | Director, Medical Science Liaison | $115.38 |
| 2026-09-30 | Deidre T George | IND | Novartis | AD State Government Affairs | $115.38 |
| 2026-09-30 | Erin Guerrero | IND | Novartis | AD State Government Affairs | $115.38 |
| 2026-09-30 | John Hohenwarter | IND | Novartis | AD State Government Affairs | $115.38 |
| 2026-09-30 | Amanda Lane | IND | Novartis Services Incorporated | Associate Director Strategic Planning | $115.38 |
| 2026-09-30 | Nisha Patel | IND | Novartis | Regional Director of Medical Science L | $115.38 |
| 2026-09-30 | Jacob Snapp | IND | Novartis | Direct Cell & Gene Therapies Product S | $115.38 |
| 2026-09-30 | Daniel Vigil | IND | Novartis | Head, State Policy and Reporting | $115.00 |
| 2026-09-30 | Robin Auth | IND | Novartis | Assoc Dir, DRA Advertising/Promotion | $100.00 |
| 2026-09-30 | Nancy J Grande | IND | Novartis | Senior Global Program Safety Lead | $100.00 |
| 2026-09-30 | Edward J Blair | IND | Novartis | Dir, Bus Planning & Strategy CE Onco | $100.00 |
| 2026-09-30 | Rebecca L Maher | IND | Novartis | Director, Commercial Access Integratio | $100.00 |
| 2026-09-30 | Daniel DiMeo | IND | Novartis | VP, Payer & Pricing Strat | $100.00 |
| 2026-09-30 | Julia A Gawel | IND | Novartis | ED, National Sales Director | $100.00 |
| 2026-09-30 | Christina Zoppi | IND | Novartis | Exec Dir, US Neuroscience Communicatio | $100.00 |
| 2026-09-30 | Timothy Swaller | IND | Novartis | Executive Director, NIBR SD Operations | $100.00 |
| 2026-09-30 | Elizabeth G McGee | IND | Novartis | Global Head of Inclusive Health Accele | $76.92 |
| 2026-09-30 | Daniel Redinger | IND | Novartis | Director, Corporate Impact and Enterpr | $76.92 |
| 2026-09-30 | Rhoda Dunn | IND | Novartis | VP, Market Access Portfolio Strategy | $76.92 |
| 2026-09-30 | Sonia Choi | IND | Novartis | Global Head, US Comms & Patient Advoca | $76.92 |
| 2026-09-30 | Nanette D Temby | IND | Novartis | Director, Special Programs | $76.92 |
| 2026-09-30 | Amar Patel | IND | Novartis | AD, Patient & Community Liaison | $76.92 |
| 2026-09-30 | Micheal Westphall | IND | Novartis | Head Rewards Business Partnering, US a | $76.92 |
| 2026-09-30 | Patrick Quinlan | IND | Novartis | Senior Area Business Leader | $76.92 |
| 2026-09-30 | Michael R Imamura | IND | Novartis | Sr. Area Business Leader | $76.92 |
| 2026-09-30 | Cynthia Repetti | IND | Novartis | Sr. Area Business Leader | $76.92 |
| 2026-09-30 | Jacqueline Fremont-Rahl | IND | Novartis | Senior Principal Scientist | $76.92 |
| 2026-09-30 | Jennifer Fernbach | IND | Novartis | ED Mktg Ops Creative and Production Op | $76.92 |
| 2026-09-30 | Laura J Owenson | IND | Novartis | AD, Market Access Engagement | $60.00 |
| 2026-09-30 | Alyss Patel | IND | Novartis | AD State Government Affairs | $60.00 |
| 2026-09-30 | Aditya Mane | IND | Novartis | Executive Director, Radioligand Therap | $50.00 |
| 2026-09-30 | Mitchell Cole | IND | Novartis | Dir, Policy Analytics, Research & Stra | $50.00 |
| 2026-09-30 | Mark Weintraub | IND | Novartis | Director, NPS Business Planning & Stra | $50.00 |
| 2026-09-30 | David Grace | IND | Novartis | Rare Renal Capabilities Lead | $50.00 |
| 2026-09-30 | Mark Fallick | IND | Novartis | Senior Medical Director | $50.00 |
| 2026-09-30 | Steven J Lusso | IND | Novartis | Sr. Area Business Leader | $42.00 |
| 2026-09-30 | Juan C Zuluaga | IND | Novartis | AD, CRM Training | $42.00 |
| 2026-09-30 | Holli Hill | IND | Novartis | AD State Government Affairs | $42.00 |
| 2026-09-30 | Thomas Algozzine | IND | Novartis | Director, Medical Science Liaison | $40.00 |
| 2026-09-30 | John J Isbell | IND | Novartis | Director of Analytical Chemistry & SD | $40.00 |
| 2026-09-30 | Hasmik Babaian | IND | Novartis | Associate Director, Priority Accounts | $38.46 |
| 2026-09-30 | Lauren McCready | IND | Novartis | Associate Director, Access & Reimburse | $38.46 |
| 2026-09-30 | Kevin Lee | IND | Novartis | Sr. Area Business Leader RLT | $38.46 |
| 2026-09-30 | Maureen Leber | IND | Novartis | Associate Director, Trade Compliance | $38.46 |
| 2026-09-30 | VILENA KATANOVA FAYNBERG | IND | US Novartis Services Inc | Executive Director US Immunology Commu | $38.46 |
| 2026-09-30 | Sharon Jenkins Smith | IND | Novartis | Associate Director - Autoinflammatory | $38.46 |
| 2026-09-30 | Jeffrey S Nash | IND | Novartis | Regional Director | $38.46 |
| 2026-09-30 | Ann Noren | IND | Novartis | Sr. Territory Account Specialist | $38.46 |
| 2026-09-30 | Derek Peterson | IND | Novartis | VP MA PS Therapeutic Area | $38.46 |
| 2026-09-30 | Lucia Gesualdo | IND | Novartis | ED, Market Access Contracting | $38.46 |
| 2026-09-30 | Jennifer Gaither | IND | Novartis | Expert Clinical Research Associate | $38.46 |
| 2026-09-30 | H Rising | IND | Novartis | Sr. Area Business Leader | $38.46 |
| 2026-09-30 | Mary Roseman | IND | Novartis | AD, Senior Thought Leader Liaison | $38.46 |
| 2026-09-30 | Elexandrea D Scheels | IND | Novartis | Executive Director, Customer Engagemen | $38.46 |
| 2026-09-30 | Siddharth Sehgal | IND | Novartis | ED, Product Strategy Lead, eBC & Kisqa | $38.46 |
| 2026-09-30 | Sheila M Softich | IND | Novartis | Executive Territory Account Specialist | $38.46 |
| 2026-09-30 | Kimberly Burney | IND | Novartis | Expert Clinical Research Associate | $38.46 |
| 2026-09-30 | Maria Vargo | IND | Novartis Services Incorporated | Patient Navigator | $38.46 |
| 2026-09-30 | Jesse Bayer | IND | Novartis | VP, Head of Cust Exp Plng & Optimizati | $38.46 |
| 2026-09-30 | Timothy Witkowski | IND | Novartis | Global Head R&D IP, Chemistry Oncology | $38.46 |
| 2026-09-30 | Maxwell Grechko | IND | Novartis | Associate Director, Issue Advocacy & S | $35.00 |
| 2026-09-30 | Michael C Barninger | IND | Novartis | Regional Director | $34.00 |
| 2026-09-30 | Konstantine G Lolos | IND | Novartis | Oncology Sr. Area Business Leader | $28.08 |
| 2026-09-30 | Sharon L Nobles | IND | Novartis | Executive Territory Account Specialist | $23.08 |
| 2026-09-30 | Sharon N Olmstead | IND | Novartis | Head Regulatory Affairs & Development | $23.08 |
| 2026-09-30 | Matthew Foster | IND | Novartis | Regional Director | $23.08 |
| 2026-09-30 | Kevin M Carl | IND | Novartis | Global Head Regulatory Affairs Develop | $23.08 |
| 2026-09-18 | Maxwell Grechko | IND | Novartis | Associate Director, Issue Advocacy & S | $35.00 |